{
    "filename": "cma.j.cn112148-20200220-00105.pdf",
    "content_type": "text/html",
    "file_size": 0,
    "metadata": {
        "identifiers": {
            "doi": "10.3760/cma.j.cn112148-20200220-00105",
            "url": "https://dx.doi.org/10.3760/cma.j.cn112148-20200220-00105"
        },
        "doi": "doi:10.3760/cma.j.cn112148-20200220-00105",
        "author": "Zhu Ruirui; Meng Kai; He Meian; Peng Yudong; Zeng Qiutang; Huang Kai; Cheng Longxian; Guan Hongquan; Leng Liang; Wang Boyuan",
        "title": "Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV",
        "date": 2020,
        "abstract": "A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020. They were divided into critical group (ICU, n=16) and general group (n=96) according to the severity of the disease and patients were followed up to the clinical endpoint. The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection.",
        "references": "",
        "references_ris": "",
        "links": [],
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": []
    },
    "sections": {
        "methods": [
            "A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020. They were divided into critical group (ICU, n=16) and general group (n=96) according to the severity of the disease and patients were followed up to the clinical endpoint. The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection."
        ],
        "results": [
            "Compared with the general group, the lymphocyte count (0.74\u00d7109 (0.34\u00d7109, 0.94\u00d7109)/L vs. 0.99\u00d7109 (0.71\u00d7109, 1.29\u00d7109)/L, P=0.03) was extremely lower in the critical group, CRP (106.98 (81.57, 135.76) mg/L vs. 34.34 (9.55,76.54) mg/L, P<0.001) and PCT (0.20 (0.15,0.48) \u03bcg/L vs. 0.11 (0.06,0.20)\u03bcg/L, P<0.001) were significantly higher in the critical group. The BMI of the critical group was significantly higher than that of the general group (25.5 (23.0, 27.5) kg/m2 vs. 22.0 (20.0, 24.0) kg/m2, P=0.003). Patients were further divided into non-survivor group (17, 15.18%) group and survivor group (95, 84.82%). Among the non-survivors, there were 88.24% (15/17) patients with BMI> 25 kg/m2, which was significantly higher than that of survivors (18.95% (18/95), P<0.001). Compared with the survived patients, oxygenation index (130 (102, 415) vs. 434 (410, 444), P<0.001) was significantly lower and lactic acid (1.70 (1.30, 3.00) mmol/L vs. 1.20 (1.10, 1.60) mmol/L, P<0.001) was significantly higher in the non-survivors. There was no significant difference in the proportion of ACEI/ARB medication between the critical group and the general group or between non-survivors and survivors (all P>0.05)."
        ],
        "conclusion": [
            "COVID-19 patients combined with CVD are associated with a higher risk of mortality. Critical patients are characterized with lower lymphocyte counts. Higher BMI are more often seen in critical patients and non-survivor. ACEI/ARB use does not affect the morbidity and mortality of COVID-19 combined with CVD. Aggravating causes of death include fulminant inflammation, lactic acid accumulation and thrombotic events."
        ],
        "introduction": []
    },
    "structured_content": {
        "Methods": [
            "A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020. They were divided into critical group (ICU, n=16) and general group (n=96) according to the severity of the disease and patients were followed up to the clinical endpoint. The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection."
        ],
        "Results": [
            "Compared with the general group, the lymphocyte count (0.74\u00d7109 (0.34\u00d7109, 0.94\u00d7109)/L vs. 0.99\u00d7109 (0.71\u00d7109, 1.29\u00d7109)/L, P=0.03) was extremely lower in the critical group, CRP (106.98 (81.57, 135.76) mg/L vs. 34.34 (9.55,76.54) mg/L, P<0.001) and PCT (0.20 (0.15,0.48) \u03bcg/L vs. 0.11 (0.06,0.20)\u03bcg/L, P<0.001) were significantly higher in the critical group. The BMI of the critical group was significantly higher than that of the general group (25.5 (23.0, 27.5) kg/m2 vs. 22.0 (20.0, 24.0) kg/m2, P=0.003). Patients were further divided into non-survivor group (17, 15.18%) group and survivor group (95, 84.82%). Among the non-survivors, there were 88.24% (15/17) patients with BMI> 25 kg/m2, which was significantly higher than that of survivors (18.95% (18/95), P<0.001). Compared with the survived patients, oxygenation index (130 (102, 415) vs. 434 (410, 444), P<0.001) was significantly lower and lactic acid (1.70 (1.30, 3.00) mmol/L vs. 1.20 (1.10, 1.60) mmol/L, P<0.001) was significantly higher in the non-survivors. There was no significant difference in the proportion of ACEI/ARB medication between the critical group and the general group or between non-survivors and survivors (all P>0.05)."
        ],
        "Conclusion": [
            "COVID-19 patients combined with CVD are associated with a higher risk of mortality. Critical patients are characterized with lower lymphocyte counts. Higher BMI are more often seen in critical patients and non-survivor. ACEI/ARB use does not affect the morbidity and mortality of COVID-19 combined with CVD. Aggravating causes of death include fulminant inflammation, lactic acid accumulation and thrombotic events."
        ]
    },
    "participants": [
        {
            "participant": "data",
            "number": 96,
            "context": "A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020. <mark class=\"stats\">They were divided into critical group (ICU, n=16) and general group (n=96) according to the severity of the disease and patients were followed up to the clinical endpoint</mark>. The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection"
        },
        {
            "participant": "data",
            "number": 96,
            "context": "A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020. <mark class=\"stats\">They were divided into critical group (ICU, n=16) and general group (n=96) according to the severity of the disease and patients were followed up to the clinical endpoint</mark>. The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection.A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020"
        },
        {
            "participant": "data",
            "number": 96,
            "context": "The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection.A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020. <mark class=\"stats\">They were divided into critical group (ICU, n=16) and general group (n=96) according to the severity of the disease and patients were followed up to the clinical endpoint</mark>. The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection"
        }
    ],
    "statistics": [
        {
            "p_value": "P=0.03",
            "context": "The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection. <mark class=\"stats\">Compared with the general group, the lymphocyte count (0.74\u00d7109 (0.34\u00d7109, 0.94\u00d7109)/L vs. 0.99\u00d7109 (0.71\u00d7109, 1.29\u00d7109)/L, P=0.03) was extremely lower in the critical group, CRP (106.98 (81.57, 135.76) mg/L vs. 34.34 (9.55,76.54) mg/L, P<0.001) and PCT (0.20 (0.15,0.48) \u03bcg/L vs. 0.11 (0.06,0.20)\u03bcg/L, P<0.001) were significantly higher in the critical group</mark>. The BMI of the critical group was significantly higher than that of the general group (25.5 (23.0, 27.5) kg/m2 vs. 22.0 (20.0, 24.0) kg/m2, P=0.003)"
        },
        {
            "p_value": "P=0.003",
            "context": "Compared with the general group, the lymphocyte count (0.74\u00d7109 (0.34\u00d7109, 0.94\u00d7109)/L vs. 0.99\u00d7109 (0.71\u00d7109, 1.29\u00d7109)/L, P=0.03) was extremely lower in the critical group, CRP (106.98 (81.57, 135.76) mg/L vs. 34.34 (9.55,76.54) mg/L, P<0.001) and PCT (0.20 (0.15,0.48) \u03bcg/L vs. 0.11 (0.06,0.20)\u03bcg/L, P<0.001) were significantly higher in the critical group. <mark class=\"stats\">The BMI of the critical group was significantly higher than that of the general group (25.5 (23.0, 27.5) kg/m2 vs. 22.0 (20.0, 24.0) kg/m2, P=0.003)</mark>. Patients were further divided into non-survivor group (17, 15.18%) group and survivor group (95, 84.82%)"
        },
        {
            "p_value": "P<0.001",
            "context": "Patients were further divided into non-survivor group (17, 15.18%) group and survivor group (95, 84.82%). <mark class=\"stats\">Among the non-survivors, there were 88.24% (15/17) patients with BMI> 25 kg/m2, which was significantly higher than that of survivors (18.95% (18/95), P<0.001)</mark>. Compared with the survived patients, oxygenation index (130 (102, 415) vs. 434 (410, 444), P<0.001) was significantly lower and lactic acid (1.70 (1.30, 3.00) mmol/L vs. 1.20 (1.10, 1.60) mmol/L, P<0.001) was significantly higher in the non-survivors"
        },
        {
            "p_value": "P<0.001",
            "context": "Among the non-survivors, there were 88.24% (15/17) patients with BMI> 25 kg/m2, which was significantly higher than that of survivors (18.95% (18/95), P<0.001). <mark class=\"stats\">Compared with the survived patients, oxygenation index (130 (102, 415) vs. 434 (410, 444), P<0.001) was significantly lower and lactic acid (1.70 (1.30, 3.00) mmol/L vs. 1.20 (1.10, 1.60) mmol/L, P<0.001) was significantly higher in the non-survivors</mark>. There was no significant difference in the proportion of ACEI/ARB medication between the critical group and the general group or between non-survivors and survivors (all P>0.05)"
        }
    ],
    "keywords": [
        "myocardial injury",
        "coagulation function",
        "observation indicator",
        "western district",
        "total blood",
        "injury marker",
        "arterial blood",
        "clinical endpoint",
        "clinical characteristic",
        "critical group",
        "COVID-19",
        "reactive protein",
        "blood gas",
        "blood count",
        "gas analysis",
        "critical patient",
        "union hospital",
        "cardiovascular disease",
        "retrospective analysis",
        "general group",
        "B-type natriuretic peptide",
        "c reactive",
        "disease patient",
        "C-reactive protein"
    ],
    "keyword_relevance": {
        "critical group": 0.15151515151515152,
        "general group": 0.12121212121212122,
        "COVID-19": 0.09090909090909091,
        "C-reactive protein": 0.09090909090909091,
        "B-type natriuretic peptide": 0.06060606060606061,
        "myocardial injury": 0.030303030303030304,
        "coagulation function": 0.030303030303030304,
        "observation indicator": 0.030303030303030304,
        "western district": 0.030303030303030304,
        "total blood": 0.030303030303030304,
        "injury marker": 0.030303030303030304,
        "arterial blood": 0.030303030303030304,
        "clinical endpoint": 0.030303030303030304,
        "clinical characteristic": 0.030303030303030304,
        "reactive protein": 0.030303030303030304,
        "blood gas": 0.030303030303030304,
        "blood count": 0.030303030303030304,
        "gas analysis": 0.030303030303030304,
        "critical patient": 0.030303030303030304,
        "cardiovascular disease": 0.030303030303030304,
        "retrospective analysis": 0.030303030303030304,
        "union hospital": 0.0,
        "c reactive": 0.0,
        "disease patient": 0.0
    },
    "species": [],
    "summary": [
        "A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020.",
        "They were divided into critical group (ICU, n=16) and general group (n=96) according to the severity of the disease and patients were followed up to the clinical endpoint.",
        "The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection.",
        "Compared with the general group, the lymphocyte count (0.74\u00d7109 (0.34\u00d7109, 0.94\u00d7109)/L vs 0.99\u00d7109 (0.71\u00d7109, 1.29\u00d7109)/L, P=0.03) was extremely lower in the critical group, CRP (106.98 (81.57, 135.76) mg/L vs 34.34 (9.55,76.54) mg/L, P<0.001) and PCT (0.20 (0.15,0.48) \u03bcg/L vs 0.11 (0.06,0.20)\u03bcg/L, P<0.001) were significantly higher in the critical group.",
        "The BMI of the critical group was significantly higher than that of the general group (25.5 (23.0, 27.5) kg/m2 vs 22.0 (20.0, 24.0) kg/m2, P=0.003).",
        "Patients were further divided into non-survivor group (17, 15.18%) group and survivor group (95, 84.82%).",
        "Among the non-survivors, there were 88.24% (15/17) patients with BMI> 25 kg/m2, which was significantly higher than that of survivors (18.95% (18/95), P<0.001).",
        "Compared with the survived patients, oxygenation index (130 (102, 415) vs 434 (410, 444), P<0.001) was significantly lower and lactic acid (1.70 (1.30, 3.00) mmol/L vs 1.20 (1.10, 1.60) mmol/L, P<0.001) was significantly higher in the non-survivors.",
        "There was no significant difference in the proportion of ACEI/ARB medication between the critical group and the general group or between non-survivors and survivors.",
        "COVID-19 patients combined with CVD are associated with a higher risk of mortality.",
        "Critical patients are characterized with lower lymphocyte counts.",
        "Higher BMI are more often seen in critical patients and non-survivor.",
        "ACEI/ARB use does not affect the morbidity and mortality of COVID-19 combined with CVD.",
        "Aggravating causes of death include fulminant inflammation, lactic acid accumulation and thrombotic events."
    ],
    "structured_summary": {
        "Introduction": [
            "A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020.",
            "They were divided into critical group (ICU, n=16) and general group (n=96) according to the severity of the disease and patients were followed up to the clinical endpoint.",
            "The observation indicators included total blood count, C-reactive protein (CRP), arterial blood gas analysis, myocardial injury markers, coagulation function, liver and kidney function, electrolyte, procalcitonin (PCT), B-type natriuretic peptide (BNP), blood lipid, pulmonary CT and pathogen detection."
        ],
        "Results": [
            "Compared with the general group, the lymphocyte count (0.74\u00d7109 (0.34\u00d7109, 0.94\u00d7109)/L vs 0.99\u00d7109 (0.71\u00d7109, 1.29\u00d7109)/L, P=0.03) was extremely lower in the critical group, CRP (106.98 (81.57, 135.76) mg/L vs 34.34 (9.55,76.54) mg/L, P<0.001) and PCT (0.20 (0.15,0.48) \u03bcg/L vs 0.11 (0.06,0.20)\u03bcg/L, P<0.001) were significantly higher in the critical group.",
            "The BMI of the critical group was significantly higher than that of the general group (25.5 (23.0, 27.5) kg/m2 vs 22.0 (20.0, 24.0) kg/m2, P=0.003).",
            "Patients were further divided into non-survivor group (17, 15.18%) group and survivor group (95, 84.82%).",
            "Among the non-survivors, there were 88.24% (15/17) patients with BMI> 25 kg/m2, which was significantly higher than that of survivors (18.95% (18/95), P<0.001).",
            "Compared with the survived patients, oxygenation index (130 (102, 415) vs 434 (410, 444), P<0.001) was significantly lower and lactic acid (1.70 (1.30, 3.00) mmol/L vs 1.20 (1.10, 1.60) mmol/L, P<0.001) was significantly higher in the non-survivors.",
            "There was no significant difference in the proportion of ACEI/ARB medication between the critical group and the general group or between non-survivors and survivors.",
            "COVID-19 patients combined with CVD are associated with a higher risk of mortality.",
            "Critical patients are characterized with lower lymphocyte counts."
        ],
        "Conclusion": [
            "Higher BMI are more often seen in critical patients and non-survivor.",
            "ACEI/ARB use does not affect the morbidity and mortality of COVID-19 combined with CVD.",
            "Aggravating causes of death include fulminant inflammation, lactic acid accumulation and thrombotic events."
        ]
    },
    "reference_links": [],
    "facts": [
        "A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district",
        "general group according to the severity of the disease and patients were followed",
        "COVID-19 patients combined with CVD are associated with a higher risk",
        "Critical patients are characterized with lower lymphocyte counts",
        "Higher BMI are more often seen in critical patients",
        "the morbidity and mortality of COVID-19 combined with CVD"
    ],
    "claims": [],
    "findings": [
        "Compared with the general group, the lymphocyte count (0.74\u00d7109 (0.34\u00d7109, 0.94\u00d7109)/L vs. 0.99\u00d7109 (0.71\u00d7109, 1.29\u00d7109)/L, P=0.03) was extremely lower in the critical group, CRP (106.98 (81.57, 135.76) mg/L vs. 34.34 (9.55,76.54) mg/L, P<0.001) and PCT (0.20 (0.15,0.48) \u03bcg/L vs. 0.11 (0.06,0.20)\u03bcg/L, P<0.001) were significantly higher in the critical group",
        "The BMI of the critical group was significantly higher than that of the general group (25.5 (23.0, 27.5) kg/m2 vs. 22.0 (20.0, 24.0) kg/m2, P=0.003)",
        "Among the non-survivors, there were 88.24% (15/17) patients with BMI> 25 kg/m2, which was significantly higher than that of survivors (18.95% (18/95), P<0.001)",
        "Compared with the survived patients, oxygenation index (130 (102, 415) vs. 434 (410, 444), P<0.001) was significantly lower and lactic acid (1.70 (1.30, 3.00) mmol/L vs. 1.20 (1.10, 1.60) mmol/L, P<0.001) was significantly higher in the non-survivors"
    ],
    "processes": [],
    "key_statements": [
        "A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020",
        "COVID-19 patients combined with CVD are associated with a higher risk of mortality",
        "Critical patients are characterized with lower lymphocyte counts",
        "Higher BMI are more often seen in critical patients and non-survivor",
        "ACEI/ARB use does not affect the morbidity and mortality of COVID-19 combined with CVD"
    ],
    "top_statements": [
        "A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020",
        "COVID-19 patients combined with CVD are associated with a higher risk of mortality",
        "Critical patients are characterized with lower lymphocyte counts",
        "Higher BMI are more often seen in critical patients and non-survivor",
        "ACEI/ARB use does not affect the morbidity and mortality of COVID-19 combined with CVD"
    ],
    "headline": "A retrospective analysis was performed on 112 COVID-19 patients with CVD admitted to the western district of Union Hospital in Wuhan, from January 20, 2020 to February 15, 2020",
    "contexts": [],
    "abbreviations": {
        "CRP": "C-reactive protein",
        "BNP": "B-type natriuretic peptide"
    }
}
